News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16 Results
Type
Article (2)
Press Release (14)
Section
Business (9)
Deals (2)
Drug Development (2)
News (12)
Tag
Alliances (4)
Clinical research (1)
Earnings (3)
IPO (2)
People (1)
Phase I (1)
Phase II (1)
Startups (1)
Date
2023 (1)
2021 (3)
2019 (1)
2018 (1)
2016 (1)
2015 (7)
2011 (2)
Location
Asia (4)
Europe (1)
16 Results for "neupharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Italfarmaco Enters Binding Term Sheet Agreement With Neupharma for an Exclusive Option to Develop and Commercialize Inhaled Teicoplanin
Italfarmaco Group announced that Italfarmaco SpA, a member company, has entered into a binding term sheet agreement with Neupharma for an exclusive option to develop and commercialize inhaled teicoplanin.
August 1, 2019
·
4 min read
Business
Coronado Biosciences Announces Exclusive Licensing Agreement With Neupharma To Develop And Commercialize Novel Covalent 3rd Generation EGFR Inhibitors
March 19, 2015
·
3 min read
Business
Simcere Pharmaceutical Group Partners Up with Suzhou NeuPharma on Cancer Drug
October 21, 2011
·
1 min read
Pharm Country
Methicillin-Resistant Staphylococcus aureus Infection Pipeline Clinical Trials Featuring 25+ companies
DelveInsight’s ‘Methicillin-Resistant Staphylococcus aureus Infection Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline methicillin-resistant Staphylococcusaureus infection therapies in various stages of clinical development.
January 25, 2023
·
13 min read
Business
Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2021, and recent corporate highlights.
May 6, 2021
·
7 min read
Business
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2020 and recent corporate highlights.
March 9, 2021
·
9 min read
Pharm Country
Checkpoint Closes $58M In Private Placement Financing
December 21, 2015
·
3 min read
Week In Review: 3SBio Inc. Rises 5% After $711 Million IPO
June 15, 2015
·
1 min read
Drug Development
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
6 of 8 pts (75%) ORR in treatment-naïve EGFR mutation-positive NSCLC patients Well-tolerated with unremarkable safety profile; No DLTs or related SAEs
September 12, 2018
·
8 min read
Business
New Company Mustang Therapeutics Formed by Coronado Biosciences, City of Hope
March 19, 2015
·
2 min read
1 of 2
Next
